PPTA Twitter

PlasmaProteins #Spring into the new season and learn more about the importance of donating #plasma . Did you know there are more than 750 donation centers in the U.S.? Learn more about how to become a part of this life-saving journey: bit.ly/2LxSFrn pic.twitter.com/wR61BcUc67
About 18 hours ago.
PlasmaProteins The PPTA promotes policies that allow access to effective treatments. Policies that restrict access can be problematic for those who rely on #plasmaprotein therapies. Learn more from @hemophiliafed 's issue brief on the impact of prior authorization: bit.ly/2TfQZmb
2 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100